Health
STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive
Meghana Keshavan and Adam Feuerstein·STAT News·November 20, 2026

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:
Read the full story at STAT News →